CLIA Kit for Ischemia Modified Albumin (IMA)
- Product No.CCA825Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range370.4-30,000ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 131.3ng/mL.
- Sample TypeSerum, plasma and other biological fluids
- Download Instruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
-
FOB
US$ 529
For more details, please contact local distributors!US$ 756
For more details, please contact local distributors! US$ 3402
For more details, please contact local distributors! US$ 6426
For more details, please contact local distributors! US$ 52920
For more details, please contact local distributors!
-
Packages (Simulation)
-
Packages (Simulation)
-
Results demonstration
-
Typical Standard Curve
-
ISO9001: 2008, ISO13485: 2003 Registered
Specificity of the CLIA Kit for Ischemia Modified Albumin (IMA)
This assay has high sensitivity and excellent specificity for detection of Ischemia Modified Albumin (IMA).
No significant cross-reactivity or interference between Ischemia Modified Albumin (IMA) and analogues was observed.
Recovery of the CLIA Kit for Ischemia Modified Albumin (IMA)
Matrices listed below were spiked with certain level of recombinant Ischemia Modified Albumin (IMA) and the recovery rates were calculated by comparing the measured value to the expected amount of Ischemia Modified Albumin (IMA) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 96-104 | 99 |
| EDTA plasma(n=5) | 91-102 | 99 |
| heparin plasma(n=5) | 90-98 | 95 |
Precision of the CLIA Kit for Ischemia Modified Albumin (IMA)
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Ischemia Modified Albumin (IMA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Ischemia Modified Albumin (IMA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity of the CLIA Kit for Ischemia Modified Albumin (IMA)
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Ischemia Modified Albumin (IMA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 89-99% | 85-93% | 95-102% | 85-101% |
| EDTA plasma(n=5) | 87-94% | 99-105% | 85-95% | 90-101% |
| heparin plasma(n=5) | 94-102% | 83-104% | 98-105% | 87-95% |
Stability of the CLIA Kit for Ischemia Modified Albumin (IMA)
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary of the CLIA Kit for Ischemia Modified Albumin (IMA)
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.
Test principle of the CLIA Kit for Ischemia Modified Albumin (IMA)
The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Ischemia Modified Albumin (IMA). A competitive inhibition reaction is launched between biotin labeled Ischemia Modified Albumin (IMA) and unlabeled Ischemia Modified Albumin (IMA) (Standards or samples) with the pre-coated antibody specific to Ischemia Modified Albumin (IMA). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Ischemia Modified Albumin (IMA) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Ischemia Modified Albumin (IMA) level in the sample or standard.
GIVEAWAYS
INCREMENT SERVICES
Related products
| Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
| NPA825Hu01 | Native Ischemia Modified Albumin (IMA) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA825Hu01 | Polyclonal Antibody to Ischemia Modified Albumin (IMA) | WB; IHC; ICC; IP. |
| LAA825Hu91 | HRP-Linked Polyclonal Antibody to Ischemia Modified Albumin (IMA) | WB; IHC; ICC. |
| SEA825Hu | ELISA Kit for Ischemia Modified Albumin (IMA) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA825Hu | ELISA Kit for Ischemia Modified Albumin (IMA) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CCA825Hu | CLIA Kit for Ischemia Modified Albumin (IMA) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA825Hu | Multiplex Assay Kit for Ischemia Modified Albumin (IMA) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
| KSA825Hu11 | ELISA Kit DIY Materials for Ischemia Modified Albumin (IMA) | Main materials for "Do It (ELISA Kit) Yourself". |